|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Net realized losses | |||||
| Additional Cash Flow Elements, Operating Activities | |||||
| Amortization of deferred policy acquisition costs | |||||
| Additions to deferred policy acquisition costs | |||||
| Depreciation and amortization | |||||
| Loss on extinguishment of debt | |||||
| Loss on sale of business | |||||
| Other operating activities, net | |||||
| Increase in reinsurance recoverables | |||||
| Net change in accrued and deferred income taxes | |||||
| Increase in insurance liabilities | |||||
| Increase (Decrease) in Premiums Receivable | |||||
| Net change in other assets and other liabilities | |||||
| Cash provided by operating activities | |||||
| Investing Activities | |||||
| Proceeds from the sale/maturity/prepayment of: | |||||
| Fixed maturities, AFS | |||||
| Proceeds From Sale and Maturity of Fair Value Option, Fixed Maturity Securties | |||||
| Proceeds from Sale and Maturity of Marketable Securities | |||||
| Mortgage loans | |||||
| Limited partnerships and other alternative investments | |||||
| Payments for the purchase of: | |||||
| Fixed maturities, AFS | |||||
| Payments for the purchase of Fair Value Option Fixed Maturity Securties | |||||
| Equity securities, at fair value | |||||
| Mortgage loans | |||||
| Limited partnerships and other alternative investments | |||||
| Net proceeds from (payments for) derivatives | |||||
| Net additions of property and equipment | |||||
| Net payments for short-term investments | |||||
| Other investing activities, net | |||||
| Proceeds from businesses sold, net of cash transferred | |||||
| Net cash used for investing activities | |||||
| Financing Activities | |||||
| Deposits and other additions to investment and universal life-type contracts | |||||
| Withdrawals and other deductions from investment and universal life-type contracts | |||||
| Repayment of debt | |||||
| Proceeds from the issuance of debt | |||||
| Net issuance (return of) shares under incentive and stock compensation plans, including related excise tax benefit | |||||
| Treasury stock acquired, including related excise tax paid | |||||
| Payments for Repurchase of Preferred Stock and Preference Stock | |||||
| Dividends paid on common stock | |||||
| Net cash used for financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | |||||
| Net increase (decrease) in cash and restricted cash, including cash classified within assets held for sale | |||||
| Less: Net decrease in cash classified as assets held for sale | |||||
| Net increase (decrease) in cash and restricted cash | |||||
| Cash and restricted cash — beginning of period | |||||
| Cash and restricted cash — end of period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Income tax paid | |||||
| Interest paid | |||||
Loading...